000			02011 a2200553 4500
005			20250514072645.0
264		0	_c20031118
008			200311s 0 0 eng d
022			_a1526-9655
024	7		_a10.3816/clm.2003.n.015 _2doi
040			_aNLM _beng _cNLM
100	1		_aTsai, Donald E
245	0	0	_aUse of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody. _h[electronic resource]
260			_bClinical lymphoma _cJun 2003
300			_a56-9 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aAntigens, CD20 _ximmunology
650	0	4	_aAntigens, Differentiation, B-Lymphocyte _ximmunology
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aCell Adhesion Molecules
650	0	4	_aDisease Progression
650	0	4	_aHumans
650	0	4	_aLectins _ximmunology
650	0	4	_aLymphoma, Non-Hodgkin _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _ximmunology
650	0	4	_aRadioimmunotherapy _xmethods
650	0	4	_aRadiopharmaceuticals
650	0	4	_aSialic Acid Binding Ig-like Lectin 2
650	0	4	_aTreatment Outcome
650	0	4	_aYttrium Radioisotopes _xtherapeutic use
700	1		_aMaillard, Ivan
700	1		_aSchuster, Stephen J
700	1		_aNasta, Sunita D
700	1		_aPorter, David L
700	1		_aKlumpp, Thomas R
700	1		_aGoldenberg, David M
700	1		_aLuger, Selina M
700	1		_aAlavi, Abass
700	1		_aSharkey, Robert M
700	1		_aHartzell, Kenneth B
700	1		_aStadtmauer, Edward A
773	0		_tClinical lymphoma _gvol. 4 _gno. 1 _gp. 56-9
856	4	0	_uhttps://doi.org/10.3816/clm.2003.n.015 _zAvailable from publisher's website
999			_c12619601 _d12619601